Cargando…
T cell-based strategies for HIV-1 vaccines
Despite 30 years of effort, we do not have an effective HIV-1 vaccine. Over the past decade, the HIV-1 vaccine field has shifted emphasis toward antibody-based vaccine strategies, following a lack of efficacy in CD8+ T-cell-based vaccine trials. Several lines of evidence, however, suggest that impro...
Autores principales: | Korber, Bette, Fischer, Will |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227724/ https://www.ncbi.nlm.nih.gov/pubmed/31584318 http://dx.doi.org/10.1080/21645515.2019.1666957 |
Ejemplares similares
-
Polyvalent vaccine approaches to combat HIV‐1 diversity
por: Korber, Bette, et al.
Publicado: (2017) -
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
por: Haynes, Barton F., et al.
Publicado: (2022) -
Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al
por: Fischer, Will, et al.
Publicado: (2008) -
Graph‐based optimization of epitope coverage for vaccine antigen design
por: Theiler, James, et al.
Publicado: (2017) -
Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
por: Theiler, James, et al.
Publicado: (2016)